Leukemia drug nilotinib safe, shows promise against Alzheimer's disease

The leukemia drug nilotinib, which shows promise in reducing the effects of Alzheimer's disease, is safe and has minimal side effects when used at low doses, according to a small clinical trial published Friday.
Source: Health News - UPI.com - Category: Consumer Health News Source Type: news